Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort.
Martino EA, Mauro FR, Reda G, Laurenti L, Visentin A, Frustaci A, Vigna E, Pepe S, Catania G, Loseto G, Murru R, Chiarenza A, Sportoletti P, Del Principe MI, Laureana R, Coscia M, Galimberti S, Ferretti E, Zucchetto A, Bomben R, Polesel J, Tedeschi A, Rossi D, Trentin L, Neri A, Morabito F, Gattei V, Gentile M. Martino EA, et al. Among authors: bomben r. Hematol Oncol. 2024 Jan;42(1):e3249. doi: 10.1002/hon.3249. Hematol Oncol. 2024. PMID: 38287529
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
Degan M, Bomben R, Bo MD, Zucchetto A, Nanni P, Rupolo M, Steffan A, Attadia V, Ballerini PF, Damiani D, Pucillo C, Poeta GD, Colombatti A, Gattei V. Degan M, et al. Among authors: bomben r. Br J Haematol. 2004 Jul;126(1):29-42. doi: 10.1111/j.1365-2141.2004.04985.x. Br J Haematol. 2004. PMID: 15198729 Free article.
Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia.
Degan M, Rupolo M, Bo MD, Stefanon A, Bomben R, Zucchetto A, Canton E, Berretta M, Nanni P, Steffan A, Ballerini PF, Damiani D, Pucillo C, Attadia V, Colombatti A, Gattei V. Degan M, et al. Among authors: bomben r. Clin Lymphoma. 2004 Sep;5(2):123-6. doi: 10.3816/clm.2004.n.019. Clin Lymphoma. 2004. PMID: 15453928
Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance.
Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Steffan A, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V. Zucchetto A, et al. Among authors: bomben r. J Immunol Methods. 2005 Oct 20;305(1):20-32. doi: 10.1016/j.jim.2005.07.004. Epub 2005 Aug 8. J Immunol Methods. 2005. PMID: 16198366
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.
Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Bulian P, Benedetti D, Rupolo M, Del Poeta G, Campanini R, Gattei V. Zucchetto A, et al. Among authors: bomben r. J Transl Med. 2006 Mar 1;4:11. doi: 10.1186/1479-5876-4-11. J Transl Med. 2006. PMID: 16509989 Free PMC article.
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S. Del Principe MI, et al. Among authors: bomben r. Blood. 2006 Aug 1;108(3):853-61. doi: 10.1182/blood-2005-12-4986. Epub 2006 Apr 6. Blood. 2006. PMID: 16601244 Free article.
127 results